Effects of venlafaxine and carbamazepine for painful peripheral diabetic neuropathy: A randomized, double-blind and double-dummy, controlled multi-center trial

Chinese Journal of Evidence-Based Medicine

Volumn 6, Issue 5, 2006, Pages 321-328

  Jia, Hai Yan ^a   Li, Qi Fu ^b   Song, Dian Ping ^c   An, Zhen Mei ^a   Liu, Yu Ping ^a   Ran, Xing Wu ^a   Wu, Ren Hua ^a   Tian, Hao Ming ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Carbamazepine; Pain; Painful peripheral diabetic neuropathy; Quality of life; Venlafaxine

Indexed keywords

CARBAMAZEPINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE;

EID: 33744943817     PISSN: 16722531     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Diabetes Control and Complication Trial Research Group: The effect of intensive treatment of diabetes on development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl Med, 1993; 329 (14): 977-986.
2. Holliday SM, Venlafax BP. A review of its pharmacology and therapeutic potential in depression. Drugs, 1995; 49(7): 280-294.
3. Khawaja IS, Feinstein RE. Cardiovascular effects of selective serotonin reuptake inhibitors and other novel antidepressants. Heart Dis, 2003; 5(2): 153-160.
4. Marchand F, Alloui A, Chapuy E, et al. The antihyperalgesic effect of venlafaxine in diabetic rats does not involve the opioid system. Neuroscience letters, 2003; 342(1-2): 105-108.
5. Lang E, Hord AH, Denson D. Venlafaxine HCL (Effexor) relieves thermal hyperalgesia in rats with an experimental mononeuropathy. Pain, 1996; 68: 151-155.
6. Kiayias JA, Vlachou ED, Lakka-Papadodima E. Venlafaxine HCL in the treatment of painful peripheral diabetic neuropathy. Diabetes Care, 2000; 23(5): 699.
7. Lithner F. Venlafaxine in treatment of severe painful peripheral diabetic neuropathy. Diabetes Care, 2000; 23(11): 1710-1711.
8. Davis JL, Smith RL. Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules. Diabetes Care, 1999; 22(11): 1909.
9. Sindrup, SH, Bach FW, Gram MC, et al. Venlafaxine versus imipramine in painful polyneuropathy: A randomized, controlled trialv. Neurology, 2003; 60(128): 1284-1289.
10. Rowbotham MC, Goli V, Kunz NR, et al. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain, 2004; 110(3): 697-706.
11. Backonja MM. Use of anticonvulsants for treatment of neuropathic pain. Nerurology, 2002; 59 (suppl 2): S14-S17.
12. Chakrabarti AK, Samantaray SK. Diabetic peripheral neuropathy: nerve conduction studies before, during and after carbamazepine therapy. Aust N Z J Med, 1976; 6(6): 565-568.
13. Gomez-Perez FJ, Choza R, Rios JM, et al. Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy. Arch Med Res, 1996; 27(4): 525-529.
14. Eisenberg E, Lurie Y, Braker C, et al. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology, 2001; 57(3): 505-509.
15. Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. Journal of Clinical Neutomuscular Disease, 2001; 3(2): 53-62.
16. Kapwz S, MannJJ MT. Antidepressant medication and the relative risk of suicide attempt and suicide. J Am Med Assoc, 1992; 268: 344-345.
17. Grothe DR, Scheckner B, Albano D. Treatment of pain syndromes with venlafaxine. Pharmacotherapy, 2004; 24(5): 621-629.
18. Muth EA, Haskins JT, Moyer JA, et al. Antidepressant biochemical profile of the novel bicyclic compound Wy-45030, an ethyl cyclohexanol derivative. Biochem Pharmacol, 1986; 35(24): 4493-4497.
19. Shen ZZ, Wu SH, Shao FY, Guohui Chen. Chronic et al. Chief editor. Complications of diabetes mellitus. Shanghai:Publishing Company of Shanghai Medical University; 1999. 261.
20. Ereshefsky L. Drug-drug interactions involving antidepressants: focus on venlafaxine. J Clin Psychopharmacol, 1996;16(3Suppl2):37-50.
21. Rudolph RL, Derivan AT. The safety and tolerability of venlafaxine HCL: analysis of the clinical trials database. J Clin Psychopharmacol, 1996; 16(suppl 12): 54-59.